Vol 9 Issue 6

CELL AND GENE THERAPY INSIGHTS

Vol 9 Issue 6

Cell and Gene Therapy Insights Vol 9 Issue 6

Download PDF

Featuring

Issue Spotlight: Gene therapy CMC & analytics
Webinars

Gene therapy CMC & analytics

Lauren Drouin

Guest Editor:

Lauren Drouin, Director, Analytical Development at Alexion, AstraZeneca Rare Disease

Interview

Assessing the AAV analytic toolkit: considerations for application & regulatory compliance

Assessing the AAV analytic toolkit: considerations for application & regulatory compliance

Juliette Reviron

Accelerating your gene therapy to patients: not all platforms are created equal

Accelerating your gene therapy to patients: not all platforms are created equal

George Buchman, Thomas VanCott

Addressing regulatory guidance for HEK293 cells and AAV-based therapeutic manufacturing

Addressing regulatory guidance for HEK293 cells and AAV-based therapeutic manufacturing

Michael Brewer

Overcoming challenges in scaled manufacturing of iPSC-derived cells

Overcoming challenges in scaled manufacturing of iPSC-derived cells

A Steinbach, D Mann, M Diakatou et al.

Aldevron case study: validation of mRNA concentration determination using variable pathlength spectroscopy

Aldevron case study: validation of mRNA concentration determination using variable pathlength spectroscopy

Joe Ferraiolo, Travis Alvine

Regulatory considerations and validation strategies for mycoplasma testing for cell-based therapies

Regulatory considerations and validation strategies for mycoplasma testing for cell-based therapies

Michael Brewer